Odyssey Therapeutics (ODTX) Cash from Financing Activities (2023 - 2026)
Odyssey Therapeutics (ODTX) reported Cash from Financing Activities of -$3.18 million for Q3 2026, compared with $90.78 million a year earlier.
Odyssey Therapeutics (ODTX) Cash from Financing Activities (2023 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Odyssey Therapeutics' Cash from Financing Activities came in at $295.41 million, up 36.4% year-over-year; for FY2025, it was $215.65 million, up 699.3% from FY2024.
- Cash from Financing Activities has a three-year compound annual growth rate of 5.7% (FY2022 to FY2025).
- By year, Cash from Financing Activities came in at $26.98 million in FY2024 (-70.7%), $92.08 million in FY2023 (-49.6%) and $182.72 million in FY2022.
- The Q3 2026 figure ranks as the lowest quarterly Cash from Financing Activities in data going back to Q4 2023.
- Year over year, Cash from Financing Activities gained in two of the last four quarters, with growth averaging 45.6%.
- Per Business Quant data, the three quarters before Q3 2026 came in at $292.16 million (Q2 2026), $484,000 (Q1 2026) and $5.94 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | -7.22 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | -8.53 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 6.82 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | -2.43 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 6.63 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | -4.39 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | -1.53 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | -2.51 Bn |
| 10 | Odyssey Therapeutics | 929.15 Mn | -64.53 Mn | - | -3.18 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -3.18 Mn |
| Jun 30, 2026 | 292.16 Mn |
| Mar 31, 2026 | 484,000.00 |
| Dec 31, 2025 | 5.94 Mn |
| Sep 30, 2025 | 90.78 Mn |
| Jun 30, 2025 | 118.72 Mn |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 6.82 Mn |
| Dec 31, 2023 | 96.60 Mn |
Odyssey Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ODTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "ODTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ODTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();